Morgan Stanley Avita Medical, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Avita Medical, Inc. stock. As of the latest transaction made, Morgan Stanley holds 222,193 shares of RCEL stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

222,193

Previous 88,013 152.45%

Holding current value

$1.23 Million

Previous $716,000 64.11%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$4.77 - $10.25 $640,038 - $1.38 Million	134,180 Added 152.45%	222,193 $1.18 Million
Q1 2025 May 15, 2025	BUY	$8.14 - $13.72 $25,209 - $42,490	3,097 Added 3.65%	88,013 $716,000
Q4 2024 Feb 14, 2025	SELL	$9.89 - $13.7 $123,595 - $171,208	-12,497 Reduced 12.83%	84,916 $1.09 Million
Q3 2024 May 14, 2025	SELL	$7.72 - $10.87 $86,610 - $121,950	-11,219 Reduced 10.33%	97,413 $1.04 Million
Q3 2024 Nov 14, 2024	SELL	$7.72 - $10.87 $86,610 - $121,950	-11,219 Reduced 10.33%	97,413 $1.04 Million
Q2 2024 May 14, 2025	BUY	$7.92 - $15.55 $187,830 - $368,783	23,716 Added 27.93%	108,632 $860,000
Q2 2024 Oct 17, 2024	BUY	$7.92 - $15.55 $545,022 - $1.07 Million	68,816 Added 172.84%	108,632 $860,000
Q2 2024 Aug 14, 2024	BUY	$7.92 - $15.55 $545,022 - $1.07 Million	68,816 Added 172.84%	108,632 $860,000
Q1 2024 Oct 17, 2024	SELL	$12.56 - $18.31 $864,328 - $1.26 Million	-68,816 Reduced 63.35%	39,816 $638,000
Q1 2024 Aug 16, 2024	SELL	$12.56 - $18.31 $282,373 - $411,645	-22,482 Reduced 36.09%	39,816 $638,000
Q1 2024 May 15, 2024	SELL	$12.56 - $18.31 $282,373 - $411,645	-22,482 Reduced 36.09%	39,816 $638,000
Q4 2023 Aug 16, 2024	SELL	$9.29 - $14.57 $430,442 - $675,086	-46,334 Reduced 42.65%	62,298 $854,000
Q4 2023 Feb 13, 2024	SELL	$9.29 - $14.57 $894,757 - $1.4 Million	-96,314 Reduced 60.72%	62,298 $854,000
Q3 2023 Nov 15, 2023	BUY	$13.84 - $20.79 $1.7 Million - $2.55 Million	122,565 Added 340.01%	158,612 $2.32 Million
Q2 2023 Aug 14, 2023	SELL	$10.7 - $17.48 $221,211 - $361,381	-20,674 Reduced 36.45%	36,047 $613,000
Q1 2023 May 15, 2023	BUY	$6.45 - $14.48 $250,666 - $562,736	38,863 Added 217.62%	56,721 $792,000
Q4 2022 Feb 14, 2023	SELL	$4.53 - $7.55 $57,037 - $95,062	-12,591 Reduced 41.35%	17,858 $117,000
Q3 2022 Nov 14, 2022	SELL	$4.97 - $7.89 $184,272 - $292,537	-37,077 Reduced 54.91%	30,449 $161,000
Q2 2022 Oct 27, 2022	BUY	$4.6 - $8.82 $150,208 - $288,008	32,654 Added 93.64%	67,526 $320,000
Q2 2022 Aug 15, 2022	BUY	$4.6 - $8.82 $150,208 - $288,008	32,654 Added 93.64%	67,526 $320,000
Q1 2022 Oct 27, 2022	SELL	$6.96 - $12.15 $227,271 - $396,746	-32,654 Reduced 48.36%	34,872 $296,000
Q1 2022 May 13, 2022	BUY	$6.96 - $12.15 $14,017 - $24,470	2,014 Added 6.13%	34,872 $296,000
Q4 2021 Feb 14, 2022	BUY	$11.72 - $19.66 $50,185 - $84,184	4,282 Added 14.98%	32,858 $393,000
Q3 2021 Nov 15, 2021	BUY	$16.73 - $20.9 $478,076 - $597,238	28,576 New	28,576 $506,000

Others Institutions Holding RCEL

# of Institutions

Shares Held

7.6M

Call Options Held

46.5K

Put Options Held

18.5K

View Full List

About AVITA Medical, Inc.

Ticker RCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,030,900
Market Cap $138M
Description
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...

More about RCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account